Patent details

Basic Information

Publication number:

EP2722034

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP131891855

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

ORAL PHARMACEUTICAL FORMULATIONS COMPRISING DABIGATRAN

French Title of Invention:

FORMULATIONS PHARMACEUTIQUES ORALES COMPRENANT DU DABIGATRAN

German Title of Invention:

ORALE PHARMAZEUTISCHE ZUSAMMENSETZUNGEN ENTHALTEND DABIGATRAN

SPC Number:

Dates

Filing date:

17/10/2013

Grant date:

16/09/2020

EP Publication Date:

23/04/2014

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

16/09/2020

EP B1 Publication Date:

16/09/2020

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

17/10/2020

Expiration date:

17/10/2033

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

09/09/2020

 

 

Name:

Sanovel Ilac Sanayi ve Ticaret A.S.

Address:

Balabandere Cad. Ilac Sanayi Yolu No: 14 Istinye, 34460 Istanbul, Türkiye (TR)

Inventor

1

Name:

Turp, Ali Hasan

Address:

Türkiye (TR)

2

Name:

Saydam, Mehtap

Address:

Türkiye (TR)

3

Name:

Türkyilmaz, Ali

Address:

Türkiye (TR)

Priority

1

Priority Number:

201212083

Priority Date:

19/10/2012

Priority Country:

Türkiye (TR)

2

Priority Number:

201311483

Priority Date:

01/10/2013

Priority Country:

Türkiye (TR)

Classification

IPC classification:

A61K 9/00; A61K 9/20; A61K 9/28; A61K 31/4184; A61K 31/4439;

Publication

European Patent Bulletin

Issue number:

202038

Publication date:

16/09/2020

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages